Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/04/2012 | EP2401266A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them |
01/04/2012 | EP2401265A2 Soluble guanylate cyclase activators |
01/04/2012 | EP2401256A1 Compounds as bradykinin b1 antagonists |
01/04/2012 | EP2400991A1 Radiolabelled pde10 ligands |
01/04/2012 | EP2400846A1 Hepatitis c virus inhibitors |
01/04/2012 | EP2265582B1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. |
01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
01/04/2012 | EP1735286B1 Tetrahydro-indazole cannabinoid modulators |
01/04/2012 | CN1972921B 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors |
01/04/2012 | CN102307872A BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases |
01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
01/04/2012 | CN102307870A Pyridyloxyindoles inhibitors of VEGF-R2 and use thereof for treatment of disease |
01/04/2012 | CN102307869A Aminopyrazine derivative and medicine |
01/04/2012 | CN102307868A Indole derivatives as anticancer agents |
01/04/2012 | CN102307867A Dihydroquinolinone derivatives |
01/04/2012 | CN102307863A Pyrimidine derivatives, horticultural insecticides comprising said derivatives and method of use thereof |
01/04/2012 | CN102307862A Compounds for treating cancer |
01/04/2012 | CN102307853A Pyrrolidine derivatives as NK3 receptor antagonists |
01/04/2012 | CN102307621A Novel cyanopyrimidine derivative |
01/04/2012 | CN102304122A Cis-nitenpyram compound containing amino-acid ester as well as preparation method and application thereof |
01/04/2012 | CN102304087A Cucoline derivative as well as salts, preparation method and application thereof |
01/04/2012 | CN102302494A Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
01/04/2012 | CN101665463B Phenyl dual-imidazole compounds, synthesis method and application thereof |
01/04/2012 | CN101550104B Benzene-naphthalene diimide derivative, preparation method and its application |
01/04/2012 | CN101528708B Indazole derivatives useful as l-cpt1 inhibitors |
01/04/2012 | CN101289444B Pyrimidine derivate and medicinal use thereof |
01/04/2012 | CN101163678B Pyridylmethylsulfone derivative |
01/04/2012 | CN101155783B Pyrazoles |
01/03/2012 | US8088925 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors |
01/03/2012 | US8088924 Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
01/03/2012 | US8088922 Dibenzorylenetetracarboximides as infrared absorbers |
01/03/2012 | US8088827 Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension |
01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
01/03/2012 | US8088800 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
01/03/2012 | US8088795 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53 |
01/03/2012 | US8088783 MAPK/ERK kinase inhibitors |
01/03/2012 | US8088774 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
01/03/2012 | US8088769 e.g. 2-(3,4-Dichlorophenyl)ethanamidine hydrochloride; phosphodiesterases inhibitor; learning enhancement, cognition activator; improving perception, concentration, or memory |
01/03/2012 | US8088767 JAK-2 modulators and methods of use |
01/03/2012 | US8088766 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
01/03/2012 | US8088368 Antiviral compounds |
01/03/2012 | CA2632194C N4-phenyl-quinazoline-4-amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
01/03/2012 | CA2536257C Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
01/03/2012 | CA2515132C Heteroaryl substituted pyrroles useful as inhibitors of protein kinases |
01/03/2012 | CA2489128C 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
01/03/2012 | CA2488565C Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
01/03/2012 | CA2484685C Optically active .beta.-aminoketones, optically active 1,3-amino alcohols and method for the production thereof |
01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
12/29/2011 | WO2011163636A2 Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms |
12/29/2011 | WO2011163594A2 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
12/29/2011 | WO2011163222A1 Nilotinib salts and crystalline forms thereof |
12/29/2011 | WO2011162409A1 Compounds having trpv1 antagonistic activity and uses thereof |
12/29/2011 | WO2011162162A1 Light-emitting device material and light-emitting device |
12/29/2011 | WO2011161945A1 Alkoxyimino derivative and pest control agent |
12/29/2011 | WO2011161615A1 5-lipoxygenase inhibitors |
12/29/2011 | WO2011161421A1 Salts and polymorphs of dexrabeprazole |
12/29/2011 | WO2011161159A1 Heterocyclic compounds, their preparation and their therapeutic application |
12/29/2011 | WO2011161076A1 Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives |
12/29/2011 | WO2011160758A1 Materials for organic electroluminescent devices |
12/29/2011 | WO2011160569A1 Pyrazolyl quinazolone compounds and uses thereof |
12/29/2011 | WO2011160568A1 3-methoxy pyrazole amide compounds and uses thereof |
12/29/2011 | WO2011139414A3 Dexlansoprazole polymorphic forms |
12/29/2011 | WO2011094496A3 Trypsin-like serine protease inhibitors, and their preparation and use |
12/29/2011 | WO2011041634A8 Pyrazole inhibitors of phosphatidylinositol 3-kinase |
12/29/2011 | US20110319626 Use of Atorvastatin Lactols as Medicaments |
12/29/2011 | US20110319616 Thiazole derivative and process for producing same |
12/29/2011 | US20110319615 Insecticidal pyrimidinyl aryl hyrdrazones |
12/29/2011 | US20110319614 Organic Compounds |
12/29/2011 | US20110319452 Cyano anthranilamide insecticides |
12/29/2011 | US20110319450 Benzimidazole compound crystal |
12/29/2011 | US20110319449 Pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
12/29/2011 | US20110319448 Guanidine-containing compounds useful as muscarinic receptor antagonists |
12/29/2011 | US20110319439 Aza pyridone analogs useful as melanin concentrating hormone receptor-1 antagonists |
12/29/2011 | US20110319434 Bicyclic Heterocyclic Derivatives and Methods of Use Thereof |
12/29/2011 | US20110319430 Fungicidal pyrazoles |
12/29/2011 | US20110319428 Thiazole derivatives as pesticides |
12/29/2011 | US20110319426 Substituted Isoindoles |
12/29/2011 | US20110319422 Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
12/29/2011 | US20110319421 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
12/29/2011 | US20110319420 Preparation method of dihydroindene amide compounds, their pharmaceutical compositions containing compounds thereof and use as protein kinases inhibitor |
12/29/2011 | US20110319416 Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions |
12/29/2011 | US20110319413 Piperazine compound capable of inhibiting prostaglandin d synthase |
12/29/2011 | US20110319412 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
12/29/2011 | US20110319411 Isoindolinone and related analogs as sirtuin modulators |
12/29/2011 | US20110319403 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
12/29/2011 | US20110319400 Prokineticin 1 receptor antagonists for the treatment of pain |
12/29/2011 | US20110319396 Benzodiazepin-2-on derivatives |
12/29/2011 | US20110319393 Anthelmintic agents and their use |
12/29/2011 | US20110319390 6-Aminoisoquinoline Compounds |
12/29/2011 | US20110319379 Substituted Indazole Amides And Their Use As Glucokinase Activators |
12/29/2011 | US20110319378 Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer |
12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
12/29/2011 | US20110318359 Method for reducing blood pressure using inhibitors of plasma kallikrein |
12/29/2011 | US20110318266 Phthalimide derivative metabotropic glutamate r4 ligands |
12/29/2011 | US20110315975 Material for use in phosphorescent device and organic electroluminescent device using same |
12/29/2011 | US20110315933 Materials for organic electroluminescent devices |
12/29/2011 | CA2803673A1 Salts and polymorphs of dexrabeprazole |
12/29/2011 | CA2803559A1 Nilotinib salts and crystalline forms thereof |
12/29/2011 | CA2803496A1 Heterocyclic compounds, their preparation and their therapeutic application |